JP2022513913A5 - - Google Patents
Info
- Publication number
- JP2022513913A5 JP2022513913A5 JP2021534341A JP2021534341A JP2022513913A5 JP 2022513913 A5 JP2022513913 A5 JP 2022513913A5 JP 2021534341 A JP2021534341 A JP 2021534341A JP 2021534341 A JP2021534341 A JP 2021534341A JP 2022513913 A5 JP2022513913 A5 JP 2022513913A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- antigenic composition
- labyrinthin
- peptide
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025003947A JP2025072379A (ja) | 2018-12-13 | 2025-01-10 | がん免疫療法のためのラビリンチンベースのペプチドとその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862779377P | 2018-12-13 | 2018-12-13 | |
| US62/779,377 | 2018-12-13 | ||
| PCT/US2019/066264 WO2020123964A1 (en) | 2018-12-13 | 2019-12-13 | Labyrinthin-based peptides for cancer immunotherapies and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025003947A Division JP2025072379A (ja) | 2018-12-13 | 2025-01-10 | がん免疫療法のためのラビリンチンベースのペプチドとその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022513913A JP2022513913A (ja) | 2022-02-09 |
| JP2022513913A5 true JP2022513913A5 (https=) | 2022-12-21 |
Family
ID=71077093
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021534341A Pending JP2022513913A (ja) | 2018-12-13 | 2019-12-13 | がん免疫療法のためのラビリンチンベースのペプチドとその使用 |
| JP2025003947A Pending JP2025072379A (ja) | 2018-12-13 | 2025-01-10 | がん免疫療法のためのラビリンチンベースのペプチドとその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025003947A Pending JP2025072379A (ja) | 2018-12-13 | 2025-01-10 | がん免疫療法のためのラビリンチンベースのペプチドとその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220409709A1 (https=) |
| EP (1) | EP3894432A4 (https=) |
| JP (2) | JP2022513913A (https=) |
| KR (2) | KR20260042221A (https=) |
| CN (1) | CN113412275A (https=) |
| AU (1) | AU2019397539B2 (https=) |
| CA (1) | CA3123396A1 (https=) |
| IL (1) | IL283933A (https=) |
| MX (1) | MX2021007074A (https=) |
| TW (1) | TW202039536A (https=) |
| WO (1) | WO2020123964A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116143868B (zh) * | 2023-01-10 | 2025-10-21 | 合肥工业大学 | 一种能够增强咸味的多肽及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8910145D0 (en) * | 1989-05-03 | 1989-06-21 | Connaught Lab | Synthetic peptides for an hiv-1 vaccine |
| US6166176A (en) * | 1998-03-17 | 2000-12-26 | Immvarx, Inc. | Cancer marker protein and peptides thereof |
| US6190670B1 (en) * | 1999-04-12 | 2001-02-20 | Immtech International Inc. | Use of mCRP to enhance immune responses |
| ATE536370T1 (de) * | 2006-02-02 | 2011-12-15 | Univ Alabama Res Found | Nicht gespulte schutzregionen der pneumokokken- oberflächenproteine pspa und pspc |
| JP2013525271A (ja) * | 2010-03-12 | 2013-06-20 | チルドレンズ メディカル センター コーポレーション | 免疫原およびそのスクリーニング方法 |
| WO2011116014A2 (en) * | 2010-03-15 | 2011-09-22 | Mission Therapeutics, Inc. | Humanized antibodies to labyrinthin and uses thereof |
| EP2607374A1 (en) * | 2011-12-21 | 2013-06-26 | Sanofi | Method for recombinant production of labyrinthopeptins and functional derivatives thereof |
| US20200190480A1 (en) * | 2017-08-30 | 2020-06-18 | Next Pharma Inc. | ANTIBODIES AGAINST ASPARTYL (ASPARAGINYL) beta-HYDROXYLASE (AABH) AND METHODS OF MAKING AND USING |
-
2019
- 2019-12-13 JP JP2021534341A patent/JP2022513913A/ja active Pending
- 2019-12-13 AU AU2019397539A patent/AU2019397539B2/en active Active
- 2019-12-13 KR KR1020267004946A patent/KR20260042221A/ko active Pending
- 2019-12-13 WO PCT/US2019/066264 patent/WO2020123964A1/en not_active Ceased
- 2019-12-13 TW TW108145889A patent/TW202039536A/zh unknown
- 2019-12-13 KR KR1020217021896A patent/KR102929753B1/ko active Active
- 2019-12-13 EP EP19895424.0A patent/EP3894432A4/en active Pending
- 2019-12-13 CA CA3123396A patent/CA3123396A1/en active Pending
- 2019-12-13 MX MX2021007074A patent/MX2021007074A/es unknown
- 2019-12-13 US US17/309,648 patent/US20220409709A1/en active Pending
- 2019-12-13 CN CN201980091552.9A patent/CN113412275A/zh active Pending
-
2021
- 2021-06-13 IL IL283933A patent/IL283933A/en unknown
-
2025
- 2025-01-10 JP JP2025003947A patent/JP2025072379A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012501959A5 (https=) | ||
| JP2023513720A5 (https=) | ||
| JP2018509935A5 (https=) | ||
| RU2015142996A (ru) | Пептидная вакцина для предупреждения и иммунотерапии деменции альцгеймеровского типа | |
| JP7072921B2 (ja) | Ａ群レンサ球菌ワクチン | |
| RU2015132962A (ru) | Иммуногенные композиции на основе вируса гриппа и их применение | |
| RU2008102930A (ru) | Способы введения вакцин, новые калицивирусы кошки и варианты лечения для иммунизации животных против парвовируса кошки и вируса герпеса кошки | |
| JP2010516290A5 (https=) | ||
| JP2013181034A5 (https=) | ||
| JP6676661B2 (ja) | ブタ生殖器呼吸器症候群及びブタサーコウイルス関連疾患に対するワクチン組成物 | |
| JP2016514713A5 (https=) | ||
| JP2024508683A5 (https=) | ||
| JP2024522385A5 (https=) | ||
| JP2015529677A5 (https=) | ||
| JP2021518129A5 (https=) | ||
| JP2009520758A5 (https=) | ||
| US20180028635A1 (en) | Composition and uses thereof | |
| JP2009500298A5 (https=) | ||
| JP2023052092A (ja) | 免疫原性組成物 | |
| RU2015106916A (ru) | Полипептиды clostridium difficile в виде вакцины | |
| MX2025010274A (es) | Composiciones para su uso en el tratamiento de clamidia | |
| US12414987B2 (en) | Phosphorylated polypeptide antigen vaccine, preparation method therefor and application thereof | |
| JP2022513913A5 (https=) | ||
| JP2018533908A5 (https=) | ||
| JP2015525794A5 (https=) |